Literature DB >> 25972639

Hypergiant hepatic hemangiomas: case series.

Devbrata R Adhikari1, Vishal Thakur1, Parag P Telavane1, Rishabh Kulkarni1, Rajinder Singh1, Rajeev M Joshi1.   

Abstract

Hemangiomas are the most common benign tumors of the liver. Hepatic hemangiomas originate from the proliferation of vascular endothelial cells, and enlarge by ectasia rather than hyperplasia. They are very variable in size and are classified accordingly and their management in the larger variety is debatable. Hypergiant hepatic hemangiomas are defined as those which are more than 10 cm in size. These are fairly uncommon in clinical practice. The treatment spectrum varies from masterly inactivity to resection depending upon a number of factors. We report a series of 10 cases of hyper giant hepatic hemangiomas studied and reviewed over a period of 5 years. These were evaluated with respect to their age, gender, clinical presentation, investigation findings, treatment offered, and final outcome. Five were treated with resection, four with enucleation, and one was kept under observation. All operated patients had an uneventful post-operative recovery and the one managed conservatively was asymptomatic on follow-up.

Entities:  

Keywords:  Enucleation of liver hemangioma; Giant liver hemangioma; Hypergiant liver hemangioma; Large liver hemangioma; Liver hemangioma; Liver resection

Year:  2014        PMID: 25972639      PMCID: PMC4425751          DOI: 10.1007/s12262-014-1104-8

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  7 in total

1.  Ultrasonography-guided percutaneous radiofrequency ablation for treatment of a huge symptomatic hepatic cavernous hemangioma.

Authors:  Won Young Tak; Soo Young Park; Seong Woo Jeon; Chang Min Cho; Young Oh Kweon; Sung Kook Kim; Yong Hwan Choi; Joon Mo Chung
Journal:  J Clin Gastroenterol       Date:  2006-02       Impact factor: 3.062

2.  Hepatic haemangiomas: possible association with IL-17.

Authors:  ZhaoJing Wang; Yifeng Yuan; Haiwen Zhuang; Runqiu Jiang; Jiajie Hou; Qi Chen; Feng Zhang
Journal:  J Clin Pathol       Date:  2011-10-26       Impact factor: 3.411

3.  Spontaneous rupture of hepatic hemangiomas: A review of the literature.

Authors:  Marcelo Af Ribeiro; Francine Papaiordanou; Juliana M Gonçalves; Eleazar Chaib
Journal:  World J Hepatol       Date:  2010-12-27

4.  Management of giant hemangioma of the liver: resection versus observation.

Authors:  Thomas Schnelldorfer; Adam L Ware; Rory Smoot; Cathy D Schleck; William S Harmsen; David M Nagorney
Journal:  J Am Coll Surg       Date:  2010-10-25       Impact factor: 6.113

5.  Hemodynamic failure as an indication to urgent liver transplantation in infants with giant hepatic hemangiomas or vascular malformations--report of four cases.

Authors:  Malgorzata Markiewicz-Kijewska; Weronika Kasprzyk; Dorota Broniszczak; Ludmila Bacewicz; Anna Ostoja-Chyzynska; Hor Ismail; Andrzej Kosciesza; Bozenna Dembowska-Baginska; Joanna Teisseyre; Przemyslaw Kluge; Grazyna Brzezinska-Rajszys; Irena Jankowska; Piotr Kalicinski
Journal:  Pediatr Transplant       Date:  2008-10-25

Review 6.  Management of giant liver hemangiomas: an update.

Authors:  Lisette T Hoekstra; Matthanja Bieze; Deha Erdogan; Joris J T H Roelofs; Ulrich H W Beuers; Thomas M van Gulik
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-03       Impact factor: 3.869

7.  Adult Kasabach-Merritt Syndrome due to Hepatic Giant Hemangioma.

Authors:  Ahmet Aslan; Andreas Meyer Zu Vilsendorf; Moritz Kleine; Martin Bredt; Hüseyin Bektas
Journal:  Case Rep Gastroenterol       Date:  2009-11-20
  7 in total
  2 in total

1.  Surgical management of giant hepatic hemangioma: A 10-year single center experience.

Authors:  Waad Farhat; Houssem Ammar; Mohamed Amine Said; Abdelkader Mizouni; Linda Ghabry; Eya Hammami; Rahul Gupta; Mohamed Ben Mabrouk; Ali Ben Ali
Journal:  Ann Med Surg (Lond)       Date:  2021-07-06

2.  Indications for liver surgery in benign tumours.

Authors:  Margot Fodor; Florian Primavesi; Eva Braunwarth; Benno Cardini; Thomas Resch; Reto Bale; Daniel Putzer; Benjamin Henninger; Rupert Oberhuber; Manuel Maglione; Christian Margreiter; Stefan Schneeberger; Dietmar Öfner; Stefan Stättner
Journal:  Eur Surg       Date:  2018-05-22       Impact factor: 0.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.